Risk stratification schemes, anticoagulation use and outcomes: the risk–treatment paradox in patients with newly diagnosed non-valvular atrial fibrillation

Roopinder K. Sandhu(University of Alberta), Finlay A. McAlister(Alliance for Canadian Health Outcomes Research in Diabetes)

Heart

November 10, 2011

10.1136/heartjnl-2011-300901

Cited by 79

Related Papers

Time in therapeutic range and stability over time for warfarin users in clinical practice: a retrospective cohort study using linked routinely collected health data in Alberta, Canada

|BMJ Open|2018|36

Impact of Rural Residence on Warfarin Use and Clinical Events in Patients with Non-Valvular Atrial Fibrillation: A Canadian Population Based Study

|PLoS ONE|2015|14